SA's medicines regulator has warned patients of disabling and potentially permanent side effects associated with quinolone and fluroquinolone antibiotics, and urged people taking these medicines to consult their doctors on whether to continue using them. Quinolone and fluroquinolones are broad-spectrum antibiotics that are widely used in SA, particularly in the private sector. They are frequently prescribed for respiratory and urinary tract infections, as well as more severe conditions. New safety information indicated a small percentage of patients could experience severe side effects lasting months or years after they stopped taking the drugs, said the South African Health Products Regulatory Authority (Sahpra). The side effects include problems with muscles, joints, tendons and the nervous system. As a result, the use of these antibiotics has been changed, it said. Quinolone and flouroquinolone antibiotics registered in SA include nalidixic acid, pipemidic acid, ciprofloxacin, of...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.